8-K - Annovis Bio, Inc. (0001477845) (Filer)
据 SEC EDGAR 8-K 文件，Annovis Bio, Inc.（CIK 0001477845）于 2026-10-30 提交 8-K，报告期为 2026-10-29，共 12 份文件。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 17:10:31
Documents
12
Period of Report
2026-10-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)
EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 261508902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov